Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium

INTRODUCTION: ALRV5XR treatment of androgenetic alopecia (AGA) and telogen effluvium (TE) has early evidence of regenerating a normal scalp hair phenotype in both sexes. DESIGN: We performed two 24-week double-blinded placebo-controlled comparison trials, one in each sex, on the ALRV5XR treatment ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldman, Peter R., Feldman, Oriel J., Guevara-Aguirre, Jaime, Fiebig, Klaus M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421616/
https://www.ncbi.nlm.nih.gov/pubmed/36045927
http://dx.doi.org/10.3389/fmed.2022.918058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421616/
https://www.ncbi.nlm.nih.gov/pubmed/36045927
http://dx.doi.org/10.3389/fmed.2022.918058

Ejemplares similares